日本語 
Biotech
Kaigene has signed this exclusive licensing arrangement with Taisho Pharmaceutical, kind of to help build and then commercialize its next-generation autoimmune treatment KG006, specifically in Japan. So basically under the…
bitBiome Inc partners with leading CMO for Product Supply
bitBiome, Inc., a biotechnology company unlocking the potential of our planet's microbes…
Fujirebio Announces Strategic Collaboration with Stanford Medicine
Fujirebio, a leading innovator in in-vitro diagnostics, announced a collaboration with Stanford Medicine…
ConcertAI Adds ASCO® Automation to AI Cancer Tools
ConcertAI, a leader in oncology generative and agentic AI SaaS and multi-modal…
Cellares with Mitsui to Launch Japan’s First IDMO Factory
Cellares, a pioneer in automated cell therapy manufacturing, in collaboration with Mitsui…
Alloy Therapeutics Launches in Japan at Shonan iPark
Alloy Therapeutics Inc., a biotechnology ecosystem company dedicated to democratizing access to…
RevolKa Raises $1.4M in Series A Extension for Therapies
RevolKa Ltd., a venture-backed biotech company providing a cutting-edge AI-driven protein engineering…
Fujifilm Finds Cancer Targeting Potential in New Peptides
FUJIFILM Corporation announces the successful validation of the cancer cell-targeting potential of…
Asahi Kasei and PeptiSystems Team Up on Peptide Tech
Asahi Kasei Bioprocess America (AKBA) and PeptiSystems have formed an exclusive global…
bitBiome Inc partners with leading CMO for Product Supply
bitBiome, Inc., a biotechnology company unlocking the potential of our planet's microbes…
Fujirebio Announces Strategic Collaboration with Stanford Medicine
Fujirebio, a leading innovator in in-vitro diagnostics, announced a collaboration with Stanford Medicine…
ConcertAI Adds ASCO® Automation to AI Cancer Tools
ConcertAI, a leader in oncology generative and agentic AI SaaS and multi-modal…
Cellares with Mitsui to Launch Japan’s First IDMO Factory
Cellares, a pioneer in automated cell therapy manufacturing, in collaboration with Mitsui…
Alloy Therapeutics Launches in Japan at Shonan iPark
Alloy Therapeutics Inc., a biotechnology ecosystem company dedicated to democratizing access to…
RevolKa Raises $1.4M in Series A Extension for Therapies
RevolKa Ltd., a venture-backed biotech company providing a cutting-edge AI-driven protein engineering…
Fujifilm Finds Cancer Targeting Potential in New Peptides
FUJIFILM Corporation announces the successful validation of the cancer cell-targeting potential of…
Asahi Kasei and PeptiSystems Team Up on Peptide Tech
Asahi Kasei Bioprocess America (AKBA) and PeptiSystems have formed an exclusive global…
English